Drug Profile


Alternative Names: Buspirone/levodopa/carbidopa; Spinalon

Latest Information Update: 29 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Universite Laval
  • Developer National Institutes of Health (USA)
  • Class Antidepressants; Antiparkinsonians; Anxiolytics; Aromatic amino acids; Catecholamines; Hydrazines; Pyrimidines; Spiro compounds
  • Mechanism of Action Decarboxylase inhibitors; Dopamine receptor agonists; Serotonin 1A receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Spinal cord injuries
  • Preclinical Multiple sclerosis

Most Recent Events

  • 28 Jan 2016 Preclinical trials in Multiple sclerosis in USA (PO)
  • 19 Jul 2013 Phase-I/II clinical trials in Spinal cord injuries in USA (PO)
  • 31 Dec 2009 Preclinical trials in Spinal cord injuries in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top